Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni

<strong>Background</strong> In January 2021, the World Health Organization published the 2021–2030 roadmap for the control of neglected tropical diseases (NTDs). The goal for schistosomiasis is to achieve elimination as a public health problem (EPHP) and elimination of transmission (EOT)...

Full description

Bibliographic Details
Main Authors:	Kura, K, Ayabina, D, Hollingsworth, TD, Anderson, RM
Format:	Journal article
Language:	English
Published:	BioMed Central 2022

Similar Items

Maintaining low prevalence of Schistosoma mansoni: modeling the effect of less frequent treatment
by: Ayabina, D, et al.
Published: (2021)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
by: Kura, K, et al.
Published: (2019)

Achieving elimination as a public health problem for Schistosoma mansoni and S. haematobium: When is community-wide treatment required?
by: Toor, J, et al.
Published: (2019)

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission.
by: Toor, J, et al.
Published: (2019)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
by: Kura, K, et al.
Published: (2020)

Policy implications of the potential use of a novel vaccine to prevent infection with schistosoma mansoni with or without mass drug administration
by: Kura, K, et al.
Published: (2020)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
by: Kura, K, et al.
Published: (2021)

Structural and kinetic analysis of Schistosoma mansoni Adenylosuccinate Lyase (SmADSL).
by: Romanello, L, et al.
Published: (2017)

Influence of Schistosoma mansoni and Hookworm infection intensities on anaemia in Ugandan villages
by: Chami, GF, et al.
Published: (2015)

Characterization of a Schistosoma mansoni NDPK expressed in sexual and digestive organs
by: Torini, JR, et al.
Published: (2019)

Association of current Schistosoma mansoni, Schistosoma japonicum, and Schistosoma mekongi infection status and intensity with periportal fibrosis: a systematic review and meta-analysis
by: Ewuzie, A, et al.
Published: (2024)

Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques
by: Chenine, A, et al.
Published: (2005)

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
by: Prada, J, et al.
Published: (2018)

Predictions of novel Schistosoma mansoni-human protein interactions consistent with experimental data
by: White Bear, Javona, et al.
Published: (2020)

In vitro and in vivo characterization of the multiple isoforms of Schistosoma mansoni hypoxanthine-guanine phosphoribosyltransferases
by: Romanello, L, et al.
Published: (2019)

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
by: Toor, J, et al.
Published: (2018)

Chemical biology for parasitology: development of chemical probes for a bromodomain in the parasite Schistosoma mansoni
by: McArdle, DJB
Published: (2023)

Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali
by: Deol, A, et al.
Published: (2016)

Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans.
by: Brown, M, et al.
Published: (2006)

Schistosoma mansoni: histological analysis of the synergistic interaction between vaccine immunity and praziquantel therapy in the lungs of mice.
by: Piper, K, et al.
Published: (1990)

The molecular structure of Schistosoma mansoni PNP isoform 2 provides insights into the nucleoside selectivity of PNPs
by: Torini, JR, et al.
Published: (2018)

Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration
by: Crellen, T, et al.
Published: (2016)

Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
by: Ayabina, DV, et al.
Published: (2021)

Mini-FLOTAC as an alternative, non-invasive diagnostic tool for Schistosoma mansoni and other trematode infections in wildlife reservoirs
by: Catalano, S, et al.
Published: (2019)

Planning schistosomiasis control: investigation of alternative sampling strategies for Schistosoma mansoni to target mass drug administration of praziquantel in East Africa
by: Sturrock, H, et al.
Published: (2011)

Planning schistosomiasis control: investigation of alternative sampling strategies for Schistosoma mansoni to target mass drug administration of praziquantel in East Africa.
by: Sturrock, H, et al.
Published: (2011)

Current water contact and Schistosoma mansoni infection have distinct determinants: a data-driven population-based study in rural Uganda
by: Kabatereine, N, et al.
Published: (2024)

Current water contact and Schistosoma mansoni infection have distinct determinants: a data-driven population-based study in rural Uganda
by: Reitzug, F, et al.
Published: (2024)

Schistosoma mansoni cathepsin D1: biochemical and biophysical characterization of the recombinant enzyme expressed in HEK293T cells
by: Araujo-Montoya, BO, et al.
Published: (2019)

Schistosoma mansoni infection risk for school-aged children clusters within households and is modified by distance to freshwater bodies
by: Lamberti, O, et al.
Published: (2021)

Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
by: Abaasa, A, et al.
Published: (2023)

Defining a prevalence level to describe the elimination of lymphatic filariasis (LF) transmission and designing monitoring and evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
by: Collyer, BS, et al.
Published: (2020)

Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination
by: Irvine, MA, et al.
Published: (2015)

A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.
by: Vignali, D, et al.
Published: (1989)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
by: Wajja, A, et al.
Published: (2017)

Operational strategies to achieve and maintain malaria elimination
by: Moonen, B, et al.
Published: (2010)

Operational strategies to achieve and maintain malaria elimination.
by: Moonen, B, et al.
Published: (2010)

High-quality Schistosoma haematobium genome achieved by single-molecule and long-range sequencing
by: Stroehlein, Andreas J, et al.
Published: (2019)

The epidemiology of periportal fibrosis and relevance of current Schistosoma mansoni infection within the context of repeated mass drug administration: a population-based, cross-sectional study in rural Uganda
by: Ajayi, S, et al.
Published: (2024)

Models of trachoma transmission and their policy implications: From control to elimination
by: Lietman, T, et al.
Published: (2018)